---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-23-000078"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2023-12-20T23:59:59+00:00"
generated_at: "2026-06-07T09:50:32.571161+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Recursion partners with Enamine to create enriched screening libraries using MatchMaker predictions on 36B compounds

## Summary
- Up to 100 biological targets selected; Recursion's MatchMaker predicts protein-ligand interactions across Enamine's 36B REAL Space compounds.
- Recursion will receive significant number of unique REAL compounds at no cost and preferential pricing on enriched libraries.
- Enamine may offer resulting libraries to customers; libraries co-branded under Enamine and MatchMaker trademarks.
- MatchMaker uses ML for binding predictions, more scalable than traditional docking; expedites wet-lab experiments.

## SEC filing metadata
- accession: 0001601830-23-000078
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2023-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/0001601830-23-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/rxrx-20231220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-23-000078
- JSON: https://secwatch.observer/filing/0001601830-23-000078.json
- Plain text: https://secwatch.observer/filing/0001601830-23-000078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.